Technology

InMode Holds Quarterly Revenue at $95.6 Million and Reaffirms 2026 Outlook

Published

Courtroom-sketch editorial illustration of a woman receiving a facial treatment with an energy-based medical device in a dark clinical setting.

Israeli medical-technology company InMode reported second-quarter revenue of $95.6 million, virtually unchanged from a year earlier, while consumables and service revenue rose 13% to $22.3 million. GAAP net income fell to $17.1 million from $26.7 million, and gross margin narrowed to 75% from 80%. The Yokneam-based company ended June with $501.1 million in cash, marketable securities and short-term deposits after repurchasing 6.38 million shares for $87.8 million. Management maintained full-year revenue guidance of $365 million to $375 million and projected non-GAAP diluted earnings of $1.29 to $1.34 per share.

Sources

Primary sources:1

Related stories

  1. NeuroThera Launches Yale Phase IIb Trial for Tourette Syndrome Treatment
  2. Silexion Reports Three-Pathway Immune Sensitization in SIL204 Cancer Study
  3. Bezeq Comparable Profit Rises 38% to NIS 315 Million in Second Quarter
  4. Caesarstone Q2 Revenue Falls to $96.6 Million as Israel Sales Climb 32%
  5. Enlight Raises 2026 Guidance as Quarterly Revenue and Income Climb 55%

Something went wrong

We couldn't complete that action. Check your connection and try again.